We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
dc.contributor.author | Tually, Pete![]() |
|
dc.contributor.author | Quinto, Virginia G.![]() |
|
dc.contributor.author | Omar, Yehia![]() |
|
dc.contributor.author | Novruzov, Fuad![]() |
|
dc.contributor.author | Yudistiro, Ryan![]() |
|
dc.contributor.author | Sathekge, Mike Machaba![]() |
|
dc.contributor.author | Currie, Geoffrey![]() |
|
dc.contributor.author | Galette, Paul![]() |
|
dc.contributor.author | Patel, Neel![]() |
|
dc.contributor.author | Brown, Tracey![]() |
|
dc.contributor.author | Bolland, Gabriel![]() |
|
dc.contributor.author | Lo Bue, Rebecca![]() |
|
dc.contributor.author | Cade, David![]() |
|
dc.date.accessioned | 2025-02-13T06:02:42Z | |
dc.date.available | 2025-02-13T06:02:42Z | |
dc.date.issued | 2024-12 | |
dc.description | DATA AVAILABITY STATEMENT: The datasets used and/or analyzed during the current study were provided within the manuscript and supplementary information files. | en_US |
dc.description.abstract | Please read abstract in article. | en_US |
dc.description.department | Nuclear Medicine | en_US |
dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
dc.description.sdg | SDG-09: Industry, innovation and infrastructure | en_US |
dc.description.sponsorship | Telix Pharmaceuticals is providing IP and, along with the Oncidium Foundation, clinical and operational support. | en_US |
dc.description.uri | https://ejhi.springeropen.com/ | en_US |
dc.identifier.citation | Tually, P., Quinto, V.G., Omar, Y., Novruzov, F., Yudistiro, R., Sathekge, M., Currie, G., Galette, P., Patel, N., Brown, T., Bolland, G., Lo, Bue R. & Cade, D. Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry. EJNMMI Reports 2024 Dec 30; 8(1): 43. doi: 10.1186/s41824-024-00226-4. | en_US |
dc.identifier.issn | 3005-074X (online) | |
dc.identifier.other | 10.1186/s41824-024-00226-4 | |
dc.identifier.uri | http://hdl.handle.net/2263/100805 | |
dc.language.iso | en | en_US |
dc.publisher | SpringerOpen | en_US |
dc.rights | © The Author(s) 2024. Open Access. This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | en_US |
dc.subject | 99mTc-HYNIC-iPSMA | en_US |
dc.subject | SPECT | en_US |
dc.subject | Tc-99m-iPSMA | en_US |
dc.subject | Prostate cancer | en_US |
dc.subject | SDG-03: Good health and well-being | en_US |
dc.subject | SDG-09: Industry, innovation and infrastructure | en_US |
dc.subject | Positron emission tomography/computed tomography (PET/CT) | en_US |
dc.subject | Prostate-specific membrane antigen (PSMA) | en_US |
dc.title | Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection : interim results from the global NOBLE registry | en_US |
dc.type | Article | en_US |